Skip to content

Press

Portfolio-Press Releases
Cerevance Appoints Sagar Vaidya, M.D. Ph.D., as Chief Medical Officer
August 12, 2024 Aug 12, 2024
BLV-Press Releases
Bioluminescence Ventures Strengthens Senior Team with Appointment of Campbell Murray as Senior Partner
July 30, 2024 Jul 30, 2024
Portfolio-Media Coverage
Mining clues from a library of brain tissue samples, Cerevance takes a precision approach to CNS disorders
July 15, 2024 Jul 15, 2024
Portfolio-Press Releases
ReCode Therapeutics Receives U.S. FDA Orphan Drug Designation for RCT1100 for the Treatment of Primary Ciliary Dyskinesia
June 27, 2024 Jun 27, 2024
Portfolio-Press Releases
New Article Published in Science Highlights the Potential of ReCode Therapeutics’ Systemic Lung Delivery and CFTR Gene Correction
June 13, 2024 Jun 13, 2024
Portfolio-Media Coverage
Cerevance and a new approach to Parkinson’s disease
June 11, 2024 Jun 11, 2024 Raising Biotech
BLV-Media Coverage
Pharma’s R&D gamble: Picking pipeline winners in a risky field
June 7, 2024 Jun 7, 2024 PharmaVoice
Events
Bioluminescence to participate in panel “Surviving Turbulence: Extending Runway and Creating Value in Healthcare and Biotech” at BIO International Convention 2024
June 4, 2024 Jun 4, 2024 San Diego, California
Portfolio-Press Releases
ReCode Therapeutics Announces Appointment of Dean J. Mitchell as Chairman of Its Board of Directors
May 13, 2024 May 13, 2024
Portfolio-Press Releases
Ensoma Appoints Accomplished Company Builder and Product Developer, Jim Burns, Ph.D., as Chief Executive Officer
May 13, 2024 May 13, 2024